PRMT2 and breast carcinoma: Recently, PRMT2 levels were found to be decreased in breast cancer cells, while knockdown of PRMT2 correlated with increased expression of both p21 [110] and cyclin D1 [111] indicating a regulatory role for PRMT2 in cell cycle progression.